These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14602090)

  • 1. Cyclothiazide binding to functionally active AMPA receptor reveals genuine allosteric interaction with agonist binding sites.
    Kovács I; Simon A; Szárics E; Barabás P; Héja L; Nyikos L; Kardos J
    Neurochem Int; 2004 Mar; 44(4):271-80. PubMed ID: 14602090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
    Lockhart B; Iop F; Closier M; Lestage P
    Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
    Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
    J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of [3H]NS 257, a novel competitive AMPA receptor antagonist, to rat brain membranes and brain sections.
    Nielsen EO; Johansen TH; Wätjen F; Drejer J
    J Neurochem; 1995 Sep; 65(3):1264-73. PubMed ID: 7543932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High- and low-affinity alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits.
    Standley S; Tocco G; Wagle N; Baudry M
    J Neurochem; 1998 Jun; 70(6):2434-45. PubMed ID: 9603208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4H-1,2,4-Pyridothiadiazine 1,1-dioxides and 2,3-dihydro-4H-1,2, 4-pyridothiadiazine 1,1-dioxides chemically related to diazoxide and cyclothiazide as powerful positive allosteric modulators of (R/S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors: design, synthesis, pharmacology, and structure-activity relationships.
    Pirotte B; Podona T; Diouf O; de Tullio P; Lebrun P; Dupont L; Somers F; Delarge J; Morain P; Lestage P; Lepagnol J; Spedding M
    J Med Chem; 1998 Jul; 41(16):2946-59. PubMed ID: 9685234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain.
    Dev KK; Petersen V; Honoré T; Henley JM
    J Neurochem; 1996 Dec; 67(6):2609-12. PubMed ID: 8931496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dualistic profile of an allosteric AMPA receptor modulator identified through studies on recombinant receptors, mouse hippocampal synapses and crystal structures.
    Christiansen GB; Harbak B; Hede SE; Gouliaev AH; Olsen L; Frydenvang K; Egebjerg J; Kastrup JS; Holm MM
    Neuroscience; 2015 Dec; 310():709-22. PubMed ID: 26450748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.
    Hennegriff M; Arai A; Kessler M; Vanderklish P; Mutneja MS; Rogers G; Neve RL; Lynch G
    J Neurochem; 1997 Jun; 68(6):2424-34. PubMed ID: 9166736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicity.
    Impagnatiello F; Oberto A; Longone P; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):7053-8. PubMed ID: 9192690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives.
    Ptak CP; Ahmed AH; Oswald RE
    Biochemistry; 2009 Sep; 48(36):8594-602. PubMed ID: 19673491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherent desensitisation-preventing properties of a novel, subtype-selective AMPA receptor agonist, (S)-CPW 399, as a possible explanation for its excitotoxic action in cultured cerebellar granule cells.
    Sinclair C; Reavy H; Grieve A; Schousboe A; Morelli E; Novellino E; Campiani G; Griffiths R
    Neurochem Int; 2003 May; 42(6):499-510. PubMed ID: 12547649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA.
    Ebert B; Madsen U; Lund TM; Lenz SM; Krogsgaard-Larsen P
    Neurochem Int; 1994 Jun; 24(6):507-15. PubMed ID: 7526921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
    Kessler M; Arai A; Quan A; Lynch G
    Mol Pharmacol; 1996 Jan; 49(1):123-31. PubMed ID: 8569697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists.
    Desai MA; Burnett JP; Ornstein PL; Schoepp DD
    J Pharmacol Exp Ther; 1995 Jan; 272(1):38-43. PubMed ID: 7529311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.